In this episode of Skincare Confidential, Dr. Ted Lain and Dr. Patti Farris discuss the latest innovations in skincare from the AAD meeting in Orlando. They explore emerging brands, new ingredients like Thiamidol, the impact of GLP-1 agonists on skin health, and the growing interest in nutraceuticals. The conversation also covers advancements in cleansing technology, the importance of addressing pre-aging and menopausal skin, and the future of growth factors and exosomes in skincare. Be sure to visit our YouTube page for more great content: https://www.youtube.com/@skincareconfidentialpodcast Takeaways: Thiamidol is a promising new ingredient for skin lightening.Hydroquinone alternatives are essential for patient safety.GLP-1 agonists are being formulated into skincare products to address skin laxity.Nutraceuticals are gaining traction as a holistic approach to skincare.Cleansing technology is evolving to leave beneficial ingredients on the skin.Pre-aging products are being developed for younger demographics.Menopausal skin care is becoming a focal point for many brands.Growth factors and exosomes are at the forefront of skincare innovation.Companies are increasingly backing their products with clinical data. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment. See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related